VRNA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Notice: This stock is marked as potentially delisted. It may not be actively trading.

Insider Ownership Percentage: 4.80%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $29,558,114.16

Verona Pharma PLC American Depositary Share Insider Trading History Chart

Verona Pharma PLC American Depositary Share Share Price & Price History

^$106.91

+0.30 (1.20%)

As of 10/7/2025 01:00 AM ET

Verona Pharma PLC American Depositary Share Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/1/2025	Andrew Fisher	General Counsel	Sell	9,584	$13.14	$125,933.76	417,903
8/1/2025	Christina Ackermann	Director	Sell	1,808	$13.14	$23,757.12	64,072
8/1/2025	David R. Ebsworth	Director	Sell	1,904	$13.14	$25,018.56	880,499
8/1/2025	David Zaccardelli	CEO	Sell	208,912	$13.14	$2,745,103.68	13,376,144
8/1/2025	James Aloysius Brady	Director	Sell	824	$13.14	$10,827.36	23,176
8/1/2025	Kathleen A. Rickard	Insider	Sell	58,336	$13.14	$766,535.04	2,607,472
8/1/2025	Kenneth Cunningham	Director	Sell	10,808	$13.14	$142,017.12	79,776
8/1/2025	Lisa Deschamps	Director	Sell	9,464	$13.14	$124,356.96	84,856
8/1/2025	Mahendra Shah	Director	Sell	3,608	$13.14	$47,409.12	93,472
8/1/2025	Mark W. Hahn	CFO	Sell	208,912	$13.14	$2,745,103.68	12,464,968
8/1/2025	Martin Edwards	Director	Sell	10,808	$13.14	$142,017.12	157,992
8/1/2025	Michael Austwick	Director	Sell	11,288	$13.14	$148,324.32	12,712
8/1/2025	Vikas Sinha	Director	Sell	4,328	$13.14	$56,869.92	94,112
6/16/2025	Andrew Fisher	General Counsel	Sell	80,000	$11.53	$922,400.00	359,999
6/11/2025	David Zaccardelli	CEO	Sell	400,000	$11.40	$4,560,000.00	13,190,168
6/11/2025	Mark W. Hahn	CFO	Sell	400,000	$11.40	$4,560,000.00	12,278,992
5/29/2025	David Zaccardelli	CEO	Sell	208,696	$9.33	$1,947,133.68	13,590,168
5/29/2025	Mark W. Hahn	CFO	Sell	204,864	$9.33	$1,911,381.12	12,678,992
5/28/2025	David Zaccardelli	CEO	Sell	157,704	$9.30	$1,466,647.20	13,798,864
5/28/2025	Mark W. Hahn	CFO	Sell	162,704	$9.30	$1,513,147.20	12,883,856
5/27/2025	David Zaccardelli	CEO	Sell	33,600	$9.53	$320,208.00	13,956,568
5/27/2025	Mark W. Hahn	CFO	Sell	32,432	$9.53	$309,076.96	13,046,560
5/6/2025	Kathleen A. Rickard	Insider	Sell	114,984	$8.82	$1,014,158.88	2,546,472
4/29/2025	Andrew Fisher	General Counsel	Sell	26,072	$8.98	$234,126.56	359,993
4/29/2025	David Zaccardelli	CEO	Sell	90,360	$8.98	$811,432.80	14,377,176
4/29/2025	Kathleen A. Rickard	Insider	Sell	34,384	$8.98	$308,768.32	2,660,656
4/29/2025	Vikas Sinha	Director	Sell	20,000	$8.92	$178,400.00	74,440
3/12/2025	Kathleen A. Rickard	Insider	Sell	79,264	$8.35	$661,854.40	2,608,976
12/6/2024	David Zaccardelli	CEO	Sell	162,800	$5.01	$815,628.00	14,204,752
12/6/2024	Mark W. Hahn	CFO	Sell	183,728	$5.01	$920,477.28	13,293,736
12/4/2024	David Zaccardelli	CEO	Sell	67,608	$5.00	$338,040.00	15,007,816
12/4/2024	Mark W. Hahn	CFO	Sell	58,184	$5.00	$290,920.00	14,117,512
12/2/2024	David Zaccardelli	CEO	Sell	3,200	$5.00	$16,000.00	15,075,424
12/2/2024	Mark W. Hahn	CFO	Sell	1,600	$5.00	$8,000.00	14,175,696
11/29/2024	David Zaccardelli	CEO	Sell	98,888	$5.01	$495,428.88	15,078,624
11/29/2024	Mark W. Hahn	CFO	Sell	98,704	$5.01	$494,507.04	14,177,296
11/27/2024	David Zaccardelli	CEO	Sell	23,240	$5.00	$116,200.00	15,177,512
11/27/2024	Mark W. Hahn	CFO	Sell	12,936	$5.00	$64,680.00	14,276,000
11/25/2024	Kathleen A. Rickard	Insider	Sell	240,000	$4.90	$1,176,000.00	2,671,480
11/25/2024	Mark W. Hahn	CFO	Sell	1,600	$5.00	$8,000.00	14,289,736
11/11/2024	David Zaccardelli	CEO	Sell	2,400	$5.00	$12,000.00	15,202,352
11/6/2024	David R. Ebsworth	Director	Buy	39,360	$4.80	$188,928.00	920,003
11/4/2024	David Zaccardelli	CEO	Sell	94,144	$4.39	$413,292.16	15,204,752
11/4/2024	Mark W. Hahn	CFO	Sell	80,784	$4.39	$354,641.76	14,293,736
11/1/2024	David Zaccardelli	CEO	Sell	46,888	$4.38	$205,369.44	15,298,896
11/1/2024	Mark W. Hahn	CFO	Sell	48,888	$4.38	$214,129.44	14,374,520
10/25/2024	David Zaccardelli	CEO	Sell	4,800	$4.38	$21,024.00	14,591,736
10/24/2024	Mark W. Hahn	CFO	Sell	141,360	$4.38	$619,156.80	13,672,560
10/23/2024	David Zaccardelli	CEO	Sell	16	$4.38	$70.08	14,736,536
10/21/2024	David Zaccardelli	CEO	Sell	110,456	$4.38	$483,797.28	14,894,464
10/21/2024	Mark W. Hahn	CFO	Sell	116,696	$4.38	$511,128.48	13,973,264
10/18/2024	David Zaccardelli	CEO	Sell	245,784	$4.38	$1,076,533.92	15,004,920
10/18/2024	Mark W. Hahn	CFO	Sell	249,728	$4.38	$1,093,808.64	14,089,960
5/3/2024	Kathleen A. Rickard	Insider	Sell	36,248	$1.96	$71,046.08	2,621,552
11/20/2023	Martin Edwards	Director	Buy	33,736	$1.84	$62,074.24	144,800
11/6/2023	David R. Ebsworth	Director	Buy	160,000	$1.98	$316,800.00	844,643
11/3/2023	Kathleen A. Rickard	Insider	Sell	58,752	$1.92	$112,803.84	2,840,640
8/7/2023	Claire Poll	General Counsel	Sell	1,512	$2.47	$3,734.64	1,907,367
8/7/2023	David Zaccardelli	CEO	Sell	8,616	$2.47	$21,281.52	16,431,800
8/7/2023	Kathleen A. Rickard	Insider	Sell	1,600	$2.47	$3,952.00	2,872,528
8/4/2023	David Zaccardelli	CEO	Sell	150,000	$2.50	$375,000.00	16,440,416
8/3/2023	Claire Poll	General Counsel	Sell	20,608	$2.54	$52,344.32	1,935,231
8/3/2023	Kathleen A. Rickard	Insider	Sell	50,600	$2.55	$129,030.00	2,902,072
8/3/2023	Mark W. Hahn	CFO	Sell	117,272	$2.54	$297,870.88	15,679,864
8/2/2023	David Zaccardelli	CEO	Sell	73,704	$2.59	$190,893.36	16,707,688
8/1/2023	Claire Poll	General Counsel	Sell	18,608	$2.68	$49,869.44	1,968,783
8/1/2023	Kathleen A. Rickard	Insider	Sell	19,736	$2.68	$52,892.48	2,966,400
8/1/2023	Mark W. Hahn	CFO	Sell	105,944	$2.68	$283,929.92	15,870,840
5/15/2023	Orbimed Advisors Llc	Director	Sell	359,713	$20.08	$7,223,037.04	3,777,778
5/11/2023	Orbimed Advisors Llc	Director	Sell	80,000	$22.26	$1,780,800.00	4,180,691
5/3/2023	Kathleen A. Rickard	Insider	Sell	28,752	$2.65	$76,192.80	2,971,136
5/1/2023	Claire Poll	General Counsel	Sell	80,376	$2.58	$207,370.08	1,979,063
5/1/2023	David Zaccardelli	CEO	Sell	455,536	$2.58	$1,175,282.88	16,887,336
5/1/2023	Kathleen A. Rickard	Insider	Sell	77,424	$2.58	$199,753.92	2,999,888
5/1/2023	Mark W. Hahn	CFO	Sell	455,528	$2.58	$1,175,262.24	15,976,784
2/1/2023	Claire Poll	General Counsel	Sell	152,000	$2.59	$393,680.00	774,256
2/1/2023	David Zaccardelli	CEO	Sell	432,928	$2.56	$1,108,295.68	17,342,872
2/1/2023	Kathleen A. Rickard	Insider	Sell	89,960	$2.56	$230,297.60	3,106,064
2/1/2023	Mark W. Hahn	CFO	Sell	413,168	$2.56	$1,057,710.08	16,432,312
12/22/2022	Claire Poll	General Counsel	Sell	240,000	$2.69	$645,600.00	774,256
12/22/2022	Orbimed Advisors Llc	Director	Sell	3,969,496	$21.77	$86,415,927.92	36,255,896
12/20/2022	David Zaccardelli	CEO	Sell	600,000	$2.12	$1,272,000.00	17,775,800

SEC Filings (Institutional Ownership Changes) for Verona Pharma PLC American Depositary Share (NASDAQ:VRNA)

85.88% of Verona Pharma PLC American Depositary Share stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Verona Pharma PLC American Depositary Share Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
12/2/2025	IFP Advisors Inc	399	$43K	0.0%	-27.1%	0.000%
12/1/2025	Polar Asset Management Partners Inc.	970,000	$103.51M	1.0%	+8,262.1%	1.125%
11/24/2025	CIBC Private Wealth Group LLC	375	$40K	0.0%	-55.1%	0.000%
11/21/2025	Alpine Global Management LLC	30,000	$3.20M	0.5%	N/A	0.035%
11/20/2025	EMC Capital Management	2,500	$0.27M	0.1%	-23.5%	0.003%
11/20/2025	Maven Securities LTD	80,000	$8.54M	0.2%	N/A	0.093%
11/17/2025	Morningstar Investment Management LLC	20,084	$2.14M	0.1%	N/A	0.023%
11/17/2025	Meteora Capital LLC	40,000	$4.27M	0.5%	N/A	0.046%
11/17/2025	First Trust Capital Management L.P.	909,123	$97.01M	6.3%	N/A	1.055%
11/17/2025	Woodline Partners LP	317,587	$33.89M	0.2%	+5.6%	0.368%
11/17/2025	Whitebox Advisors LLC	1,566,501	$167.16M	2.6%	N/A	1.817%
11/17/2025	Verition Fund Management LLC	517,012	$55.17M	0.2%	+3,863.9%	0.600%
11/17/2025	Summit Partners Public Asset Management LLC	1,785,407	$190.52M	4.0%	+139.9%	2.071%
11/17/2025	SIH Partners LLLP	5,366	$0.57M	0.0%	+12.8%	0.006%
11/17/2025	Quantessence Capital LLC	110,237	$11.76M	3.7%	N/A	0.128%
11/17/2025	Quarry LP	99,300	$10.60M	2.3%	+5,741.2%	0.115%
11/17/2025	Qube Research & Technologies Ltd	811,841	$86.63M	0.1%	+153.9%	0.942%
11/17/2025	Prelude Capital Management LLC	160,565	$17.13M	1.3%	N/A	0.186%
11/17/2025	PenderFund Capital Management Ltd.	3,900	$0.42M	0.1%	N/A	0.005%
11/17/2025	Pentwater Capital Management LP	5,300,000	$565.56M	3.2%	N/A	6.149%
11/17/2025	Nomura Holdings Inc.	92,298	$9.85M	0.0%	N/A	0.107%
11/17/2025	Mariner LLC	3,567	$0.38M	0.0%	+22.5%	0.004%
11/17/2025	MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd.	6,176	$0.66M	0.0%	N/A	0.007%
11/17/2025	Lighthouse Investment Partners LLC	23,217	$2.48M	0.1%	N/A	0.027%
11/17/2025	Focus Partners Wealth	150,005	$16.01M	0.0%	N/A	0.174%
11/17/2025	Eventide Asset Management LLC	680,929	$72.66M	1.2%	-74.9%	0.790%
11/17/2025	Capula Management Ltd	295,665	$31.55M	0.2%	N/A	0.343%
11/17/2025	Cinctive Capital Management LP	221,054	$23.59M	1.1%	+270.6%	0.256%
11/17/2025	Bank of America Corp DE	721,212	$76.96M	0.0%	+59.1%	0.837%
11/17/2025	Alliancebernstein L.P.	718,343	$76.65M	0.0%	+490.8%	0.833%
11/17/2025	Ameriprise Financial Inc.	95,539	$10.20M	0.0%	-16.8%	0.111%
11/17/2025	Angelo Gordon & CO. L.P.	145,000	$15.47M	1.9%	N/A	0.168%
11/14/2025	Schonfeld Strategic Advisors LLC	438,062	$46.75M	0.3%	+919.9%	0.508%
11/14/2025	Polar Asset Management Partners Inc.	970,000	$103.51M	1.2%	+8,262.1%	1.125%
11/14/2025	SummitTX Capital L.P.	32,500	$3.47M	0.1%	N/A	0.038%
11/14/2025	AQR Arbitrage LLC	513,778	$54.83M	1.4%	N/A	0.596%
11/14/2025	Raymond James Financial Inc.	7,302	$0.78M	0.0%	-65.3%	0.008%
11/14/2025	Virtu Financial LLC	35,703	$3.81M	0.2%	+763.4%	0.041%
11/14/2025	Twin Securities Inc.	501,113	$53.47M	26.6%	N/A	0.581%
11/14/2025	Man Group plc	415,732	$44.36M	0.1%	N/A	0.482%
11/14/2025	ADAR1 Capital Management LLC	51,450	$5.49M	0.5%	+80.8%	0.060%
11/14/2025	Davidson Kempner Capital Management LP	3,271,623	$349.12M	5.9%	N/A	3.796%
11/14/2025	Balyasny Asset Management L.P.	1,863,426	$198.85M	0.3%	+213.9%	2.162%
11/14/2025	Brooklyn Investment Group	1,970	$0.21M	0.0%	+824.9%	0.002%
11/14/2025	Vazirani Asset Management LLC	60,000	$6.40M	22.9%	N/A	0.070%
11/14/2025	Two Sigma Investments LP	49,997	$5.34M	0.0%	-85.7%	0.058%
11/14/2025	Squarepoint Ops LLC	42,229	$4.51M	0.0%	+659.7%	0.049%
11/14/2025	Melqart Asset Management UK Ltd	107,991	$11.52M	1.5%	N/A	0.125%
11/14/2025	Slotnik Capital LLC	170,834	$18.23M	5.7%	N/A	0.198%
11/14/2025	FORA Capital LLC	11,623	$1.24M	0.2%	-15.4%	0.013%
11/13/2025	Marshall Wace LLP	147,768	$15.77M	0.0%	+460.8%	0.171%
11/13/2025	Kennedy Capital Management LLC	98,378	$10.50M	0.2%	-9.8%	0.114%
11/13/2025	Arrowstreet Capital Limited Partnership	185,303	$19.77M	0.0%	N/A	0.215%
11/13/2025	Sei Investments Co.	13,964	$1.49M	0.0%	-87.5%	0.016%
11/13/2025	UBS Group AG	89,887	$9.59M	0.0%	-92.4%	0.104%
11/13/2025	Atika Capital Management LLC	176,000	$18.78M	1.5%	-17.2%	0.204%
11/13/2025	Barometer Capital Management Inc.	19,500	$2.08M	0.5%	+77.3%	0.023%
11/13/2025	BNP Paribas Financial Markets	1,104	$0.12M	0.0%	-99.4%	0.001%
11/13/2025	Franklin Resources Inc.	127,177	$13.57M	0.0%	-89.0%	0.148%
11/13/2025	Magnetar Financial LLC	628,260	$67.04M	0.4%	N/A	0.729%
11/13/2025	Legal & General Group Plc	81,654	$8.72M	0.0%	+1.7%	0.095%
11/13/2025	Vestcor Inc	75,000	$8M	0.2%	N/A	0.087%
11/13/2025	Russell Investments Group Ltd.	16,858	$1.80M	0.0%	-88.1%	0.020%
11/13/2025	Yakira Capital Management Inc.	98,500	$10.51M	3.7%	N/A	0.114%
11/13/2025	Rathbones Group PLC	2,275	$0.24M	0.0%	-66.9%	0.003%
11/13/2025	Grantham Mayo Van Otterloo & Co. LLC	264,115	$28.18M	0.1%	N/A	0.306%
11/13/2025	Knott David M Jr	38,355	$4.09M	1.7%	-30.3%	0.045%
11/12/2025	Gabelli Funds LLC	372,744	$39.78M	0.3%	N/A	0.432%
11/12/2025	Gamco Investors INC. ET AL	163,800	$17.48M	0.2%	N/A	0.190%
11/12/2025	GABELLI & Co INVESTMENT ADVISERS INC.	265,266	$28.31M	4.5%	N/A	0.308%
11/12/2025	Longfellow Investment Management Co. LLC	713	$76K	0.0%	N/A	0.001%
11/12/2025	Barclays PLC	1,393,716	$148.72M	0.0%	+1,160.0%	1.617%
11/12/2025	Crossmark Global Holdings Inc.	14,068	$1.50M	0.0%	+15.9%	0.016%
11/12/2025	Picton Mahoney Asset Management	245,000	$26.14M	0.2%	N/A	0.284%
11/12/2025	Burren Capital Advisors Ltd	63,198	$6.74M	19.1%	N/A	0.073%
11/12/2025	R Squared Ltd	2,831	$0.30M	0.1%	-10.5%	0.003%
11/12/2025	US Bancorp DE	6,762	$0.72M	0.0%	-14.5%	0.008%
11/10/2025	Jacobson & Schmitt Advisors LLC	21,374	$2.28M	0.4%	-43.3%	0.025%
11/10/2025	Clearstead Advisors LLC	500	$53K	0.0%	-69.8%	0.001%
11/10/2025	Gardner Lewis Asset Management L P	165,592	$17.67M	4.2%	N/A	0.192%
11/10/2025	Highbridge Capital Management LLC	500,000	$53.36M	2.4%	N/A	0.580%
11/10/2025	Citigroup Inc.	231,508	$24.70M	0.0%	+4,199.9%	0.269%
11/10/2025	BCK Capital Management LP	8,816	$0.94M	1.0%	N/A	0.010%
11/10/2025	China Universal Asset Management Co. Ltd.	14,838	$1.58M	0.1%	-35.4%	0.017%
11/7/2025	Chicago Capital Management LLC	129,600	$13.83M	12.4%	N/A	0.150%
11/7/2025	Alberta Investment Management Corp	50,000	$5.34M	0.1%	N/A	0.058%
11/7/2025	CenterBook Partners LP	11,334	$1.21M	0.1%	+181.5%	0.013%
11/7/2025	Readystate Asset Management LP	262,265	$27.99M	1.2%	+376.8%	0.304%
11/7/2025	Zweig DiMenna Associates LLC	72,518	$7.74M	0.5%	-2.3%	0.084%
11/7/2025	GSA Capital Partners LLP	11,198	$1.20M	0.1%	+53.3%	0.013%
11/7/2025	Skandinaviska Enskilda Banken AB publ	36,600	$3.90M	0.0%	N/A	0.042%
11/7/2025	Credit Industriel ET Commercial	137,552	$14.68M	1.2%	N/A	0.160%
11/7/2025	JPMorgan Chase & Co.	1,414,770	$150.97M	0.0%	+347.4%	1.641%
11/7/2025	Main Street Group LTD	400	$43K	0.0%	-20.0%	0.000%
11/7/2025	TimesSquare Capital Management LLC	63,430	$6.77M	0.1%	-87.1%	0.074%
11/6/2025	Alpine Associates Management Inc.	1,157,050	$123.47M	7.5%	N/A	1.342%
11/6/2025	Wedbush Securities Inc.	2,385	$0.26M	0.0%	-11.2%	0.003%
11/6/2025	Caprock Group LLC	6,395	$0.68M	0.0%	N/A	0.007%
11/6/2025	ABC Arbitrage SA	63,196	$6.74M	0.7%	N/A	0.073%
11/6/2025	ProShare Advisors LLC	5,676	$0.61M	0.0%	+93.2%	0.007%

Data available starting January 2016

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet medical needs. The company's product candidate is ensifentrine, an inhaled and dual inhibitor of the phosphodiesterase (PDE) 3 and PDE4 enzymes that acts as both a bronchodilator and an anti-inflammatory agent in a single compound, which is in Phase 3 clinical trials for the treatment of chronic obstructive pulmonary disease, asthma, and cystic fibrosis. It is developing ensifentrine in three formulations, including nebulizer, dry powder inhaler, and pressurized metered-dose inhaler. The company was incorporated in 2005 and is headquartered in London, the United Kingdom.

Today's Range

Now: $106.91

$106.91

50 Day Range

MA: $106.65

$105.91

$106.95

52 Week Range

Now: $106.91

$31.09

$106.93

Volume

N/A

Average Volume

1,457,608 shs

Market Capitalization

$9.21 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.05

Who are the company insiders with the largest holdings of Verona Pharma PLC American Depositary Share?: Verona Pharma PLC American Depositary Share's top insider shareholders include:
David Zaccardelli (CEO)
Mark W Hahn (CFO)
Kathleen A Rickard (Insider)
David R Ebsworth (Director)
Andrew Fisher (General Counsel)
Martin Edwards (Director)
Vikas Sinha (Director)
Mahendra Shah (Director)
Lisa Deschamps (Director)
Kenneth Cunningham (Director)
Christina Ackermann (Director)
James Aloysius Brady (Director)
Michael Austwick (Director)
Learn More about top insider investors at Verona Pharma PLC American Depositary Share.
Who are the major institutional investors of Verona Pharma PLC American Depositary Share?: Verona Pharma PLC American Depositary Share's top institutional investors include:
Pentwater Capital Management LP — 6.15%
Davidson Kempner Capital Management LP — 3.80%
Balyasny Asset Management L.P. — 2.16%
Summit Partners Public Asset Management LLC — 2.07%
Whitebox Advisors LLC — 1.82%
JPMorgan Chase & Co. — 1.64%
Learn More about top institutional investors of Verona Pharma PLC American Depositary Share stock.
Which major investors are selling Verona Pharma PLC American Depositary Share stock?: Within the previous quarter, VRNA stock was sold by these institutional investors:
Eventide Asset Management LLC
UBS Group AG
Franklin Resources Inc.
Susquehanna International Group LLP
Rice Hall James & Associates LLC
TimesSquare Capital Management LLC
Two Sigma Investments LP
Group One Trading LLC
Within the last year, company insiders that have sold Verona Pharma PLC American Depositary Share company stock include:
David Zaccardelli (CEO)
Mark W Hahn (CFO)
Kathleen A Rickard (Insider)
David R Ebsworth (Director)
Andrew Fisher (General Counsel)
Martin Edwards (Director)
Vikas Sinha (Director)
Mahendra Shah (Director)
Lisa Deschamps (Director)
Kenneth Cunningham (Director)
Christina Ackermann (Director)
James Aloysius Brady (Director)
Michael Austwick (Director)
Learn More investors selling Verona Pharma PLC American Depositary Share stock.
Which major investors are buying Verona Pharma PLC American Depositary Share stock?: In the last quarter, VRNA stock was bought by institutional investors including:
Pentwater Capital Management LP
Davidson Kempner Capital Management LP
Whitebox Advisors LLC
Barclays PLC
Balyasny Asset Management L.P.
Syquant Capital Sas
Alpine Associates Management Inc.
JPMorgan Chase & Co.